BrainsWay Ltd. (BWAY)
USD 9.08
(-4.32%)
USD 9.08
(-4.32%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.92 Million USD | 61.15% |
| 2022 | -12.68 Million USD | -153.71% |
| 2021 | -4.99 Million USD | -3.52% |
| 2020 | -4.82 Million USD | 43.03% |
| 2019 | -8.47 Million USD | -65.74% |
| 2018 | -5.11 Million USD | 22.64% |
| 2017 | -6.61 Million USD | -219.53% |
| 2016 | -2.06 Million USD | 54.07% |
| 2015 | -4.5 Million USD | 38.09% |
| 2014 | -7.27 Million USD | -70.54% |
| 2013 | -4.26 Million USD | 24.92% |
| 2012 | -5.68 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 586 Thousand USD | 530.11% |
| 2024 Q1 | 93 Thousand USD | -99.08% |
| 2023 FY | -4.92 Million USD | 61.15% |
| 2023 Q2 | -1.34 Million USD | 63.38% |
| 2023 Q1 | -3.66 Million USD | 15.17% |
| 2023 Q4 | 184 Thousand USD | 238.35% |
| 2023 Q3 | -133 Thousand USD | 90.1% |
| 2022 Q1 | -1.48 Million USD | -2.07% |
| 2022 FY | -12.68 Million USD | -153.71% |
| 2022 Q4 | -4.32 Million USD | 11.23% |
| 2022 Q3 | -4.87 Million USD | -142.53% |
| 2022 Q2 | -2 Million USD | -35.49% |
| 2021 Q3 | -1.23 Million USD | 18.51% |
| 2021 Q1 | -2.15 Million USD | -429.73% |
| 2021 FY | -4.99 Million USD | -3.52% |
| 2021 Q2 | -1.51 Million USD | 29.82% |
| 2021 Q4 | -1.45 Million USD | -17.76% |
| 2020 Q2 | 215 Thousand USD | 105.94% |
| 2020 Q4 | -407 Thousand USD | -169.45% |
| 2020 FY | -4.82 Million USD | 43.03% |
| 2020 Q1 | -3.62 Million USD | -81.87% |
| 2020 Q3 | 586 Thousand USD | 172.56% |
| 2019 Q4 | -1.99 Million USD | 8.46% |
| 2019 Q2 | -2.7 Million USD | -67.87% |
| 2019 FY | -8.47 Million USD | -65.74% |
| 2019 Q1 | -1.6 Million USD | 8.16% |
| 2019 Q3 | -2.17 Million USD | 19.47% |
| 2018 Q4 | -1.75 Million USD | -86.18% |
| 2018 Q3 | -941 Thousand USD | 6.27% |
| 2018 FY | -5.11 Million USD | 22.64% |
| 2018 Q2 | -1 Million USD | -170.85% |
| 2018 Q1 | 1.41 Million USD | 168.29% |
| 2017 Q2 | -1.78 Million USD | -20.65% |
| 2017 Q4 | -2.07 Million USD | -63.9% |
| 2017 Q3 | -1.26 Million USD | 29.19% |
| 2017 Q1 | -1.48 Million USD | -6.24% |
| 2017 FY | -6.61 Million USD | -219.53% |
| 2016 Q1 | -1.17 Million USD | 37.82% |
| 2016 FY | -2.06 Million USD | 54.07% |
| 2016 Q4 | -1.39 Million USD | -163.21% |
| 2016 Q3 | -530 Thousand USD | -151.56% |
| 2016 Q2 | 1.02 Million USD | 187.71% |
| 2015 FY | -4.5 Million USD | 38.09% |
| 2015 Q4 | -1.88 Million USD | -304.24% |
| 2015 Q3 | -466.26 Thousand USD | 48.11% |
| 2015 Q1 | 5.06 Million USD | 326.64% |
| 2015 Q2 | -898.47 Thousand USD | -117.73% |
| 2014 Q4 | -2.23 Million USD | 12.18% |
| 2014 FY | -7.27 Million USD | -70.54% |
| 2014 Q1 | 4.63 Million USD | 472.05% |
| 2014 Q3 | -2.54 Million USD | -91.53% |
| 2014 Q2 | -1.32 Million USD | -128.68% |
| 2013 Q3 | -1.22 Million USD | -100.6% |
| 2013 Q4 | -1.24 Million USD | -1.51% |
| 2013 FY | -4.26 Million USD | 24.92% |
| 2013 Q1 | -1.24 Million USD | 22.18% |
| 2013 Q2 | -611.66 Thousand USD | 50.88% |
| 2012 Q3 | -1.54 Million USD | 0.0% |
| 2012 FY | -5.68 Million USD | 0.0% |
| 2012 Q4 | -1.6 Million USD | -3.53% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 65.692% |
| Cerus Corporation | -30.05 Million USD | 83.606% |
| OrthoPediatrics Corp. | -25.76 Million USD | 80.878% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 53.612% |
| Talis Biomedical Corporation | -66.81 Million USD | 92.626% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 71.514% |
| Inogen, Inc. | -109.38 Million USD | 95.496% |
| Spectral AI, Inc. | -12.98 Million USD | 62.053% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 92.128% |
| CVRx, Inc. | -43.1 Million USD | 88.569% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -39.654% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 60.356% |
| Orthofix Medical Inc. | -139.11 Million USD | 96.458% |
| Venus Concept Inc. | -28.3 Million USD | 82.596% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 90.881% |
| Bioventus Inc. | -81.72 Million USD | 93.971% |
| Envoy Medical, Inc. | -18.37 Million USD | 73.181% |
| electroCore, Inc. | -18.8 Million USD | 73.8% |
| IceCure Medical Ltd | -15.57 Million USD | 68.368% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 89.837% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 71.468% |
| MaxCyte, Inc. | -48.29 Million USD | 89.799% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 58.788% |
| Nexalin Technology, Inc. | -5.69 Million USD | 13.505% |
| PAVmed Inc | -68.79 Million USD | 92.838% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 91.289% |
| RxSight, Inc. | -50.08 Million USD | 90.163% |
| Sight Sciences, Inc. | -57.27 Million USD | 91.397% |
| SI-BONE, Inc. | -46.93 Million USD | 89.502% |
| TELA Bio, Inc. | -44.07 Million USD | 88.821% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 90.901% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 90.42% |
| LivaNova PLC | -68.49 Million USD | 92.807% |
| 908 Devices Inc. | -42.75 Million USD | 88.477% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 97.159% |
| Nemaura Medical Inc. | -9.59 Million USD | 48.652% |
| NeuroPace, Inc. | -27.17 Million USD | 81.869% |
| LENSAR, Inc. | -12.22 Million USD | 59.711% |
| Apyx Medical Corporation | -17.25 Million USD | 71.453% |
| Cutera, Inc. | -156.23 Million USD | 96.846% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 42.736% |
| BioSig Technologies, Inc. | -28.51 Million USD | 82.72% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 94.378% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 78.05% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 104.418% |
| Axonics, Inc. | -26.05 Million USD | 81.091% |
| Outset Medical, Inc. | -169.77 Million USD | 97.098% |
| IRIDEX Corporation | -10 Million USD | 50.764% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 95.487% |
| IRadimed Corporation | 20.03 Million USD | 124.591% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 40.243% |
| INVO Bioscience, Inc. | -6.76 Million USD | 27.192% |
| Telesis Bio, Inc. | -35.15 Million USD | 85.983% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 134.382% |
| Varex Imaging Corporation | 32.1 Million USD | 115.349% |
| Quipt Home Medical Corp. | 3.91 Million USD | 225.721% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 59.392% |
| Pulmonx Corporation | -61.93 Million USD | 92.045% |
| Dynatronics Corporation | -2.27 Million USD | -116.757% |
| Modular Medical, Inc. | -17.52 Million USD | 71.892% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 66.343% |
| Semler Scientific, Inc. | 22.25 Million USD | 122.138% |
| InMode Ltd. | 195.66 Million USD | 102.518% |
| Bruker Corporation | 436.9 Million USD | 101.128% |
| Cytosorbents Corporation | -31.2 Million USD | 84.213% |
| DexCom, Inc. | 597.7 Million USD | 100.824% |
| Align Technology, Inc. | 643.33 Million USD | 100.766% |
| Viveve Medical, Inc. | -21.55 Million USD | 77.14% |
| ZimVie Inc. | -30.93 Million USD | 84.075% |
| Movano Inc. | -29.69 Million USD | 83.405% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 82.306% |
| Nexalin Technology, Inc. | -5.69 Million USD | 13.505% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -39.654% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 97.887% |
| Profound Medical Corp. | -28.61 Million USD | 82.782% |
| Insulet Corporation | 220 Million USD | 102.24% |
| enVVeno Medical Corporation | -25.23 Million USD | 80.478% |
| Surmodics, Inc. | -5.64 Million USD | 12.719% |
| iCAD, Inc. | -7.68 Million USD | 35.921% |
| Nuwellis, Inc. | -17.63 Million USD | 72.053% |
| Biotricity, Inc. | -8.82 Million USD | 44.191% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 96.063% |
| Aethlon Medical, Inc. | -12.63 Million USD | 61.01% |
| InspireMD, Inc. | -21.14 Million USD | 76.697% |
| PAVmed Inc. | -68.79 Million USD | 92.838% |
| BIOLASE, Inc. | -17.93 Million USD | 72.532% |
| Beyond Air, Inc. | -63 Million USD | 92.18% |
| FONAR Corporation | 16.53 Million USD | 129.797% |
| AxoGen, Inc. | -21.46 Million USD | 77.043% |
| Vivani Medical, Inc. | -26.96 Million USD | 81.728% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 127.31% |
| Inari Medical, Inc. | -14.03 Million USD | 64.887% |
| UFP Technologies, Inc. | 57.66 Million USD | 108.544% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 0.012% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 21.865% |
| Tenon Medical, Inc. | -15.72 Million USD | 68.672% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 34.078% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 88.463% |
| AdaptHealth Corp. | -598.4 Million USD | 99.177% |
| Sintx Technologies, Inc. | -13.35 Million USD | 63.116% |
| NanoVibronix, Inc. | -3.43 Million USD | -43.393% |
| Quanterix Corporation | -49.7 Million USD | 90.087% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 59.392% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -1189.791% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 98.527% |
| TransMedics Group, Inc. | -28.72 Million USD | 82.849% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 79.133% |
| NeuroMetrix, Inc. | -7.15 Million USD | 31.106% |
| Hyperfine, Inc. | -48.11 Million USD | 89.76% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 92.423% |
| Biomerica, Inc. | -6.36 Million USD | 22.617% |
| Bone Biologics Corporation | -9.42 Million USD | 47.742% |
| AVITA Medical, Inc. | -40.4 Million USD | 87.805% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 52.217% |
| Silk Road Medical, Inc | -59.27 Million USD | 91.687% |